SCHEMBL25537768

SCHEMBL25537768

CC1(C)c2ccccc2-c2c(-c3cc(-c4ccc(-c5ccc(-c6cccc7c6-c6c(ccc8ccccc68)C7(C)C)c6ccccc56)c5ccccc45)nc(-c4ccccc4)n3)cccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
DNMT1 P26358 1/20 0.32
MAOB P27338 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25536599 1.00 MAPT (0.34) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25536567 0.94 ALDH1A1 (0.39) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25537762 0.94 ALDH1A1 (0.39) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25537395 0.94 ENPP3 (0.33) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25537555 0.94 KDM4E (0.33) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25537755 0.93 MEN1 (0.36) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25536554 0.93 MEN1 (0.36) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25539023 0.93 PSD (0.32) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25534057 0.92 ALDH1A1 (0.40) MAPTSMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25534096 0.92 MAOB (0.35) MAPTSMN1; SMN2ALDH1A1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MAPT 1595/4885SMN1; SMN2 2672/4885ALDH1A1 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.